Sintilimab With Chemotherapy Plus PEG-rhG-GSF for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma
Clinical trial NCT06563869 · RECRUITING
Trial details
- NCT number
- NCT06563869
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-02
- Primary completion
- 2025-11-22
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.